For the latest COVID-19 information for Massey, visit

News Center

Latest News

Charles Geyer named associate director for clinical research

May 30, 2013


Charles Edward Geyer, Jr., M.D., F.A.C.P., has been named associate director for clinical research at Virginia Commonwealth University Massey Cancer Center and a professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the VCU School of Medicine, effective June 1, 2013.

Geyer comes to VCU from The University of Texas Southwestern Medical Center in Dallas, where he was an associate professor in the Division of Hematology He was also previously president and chief medical officer of the Statewide Clinical Trials Network of Texas (CTNet), a network of academic and community-based cancer centers across Texas collaborating on cancer clinical research.

A board certified medical oncologist and clinical researcher, Geyer is internationally recognized for his expertise in the study and treatment of breast cancer. From 2004 to 2011, he served as the director of medical affairs at the National Surgical Adjuvant Breast and Bowel Project (NSABP), where he was responsible for the development and oversight of the national cooperative group’s clinical studies for breast and colorectal cancers. He was also the founding co-chairman of the NCI (National Cancer Institute) Breast Cancer Steering Committee, which coordinates the nation’s process for identifying and promoting the “best science” in breast cancer clinical research by addressing the design and prioritization of phase 3 and large phase 2 trials for breast cancer.

As the associate director for clinical research at Massey, Geyer will serve on the cancer center’s Executive Committee and will oversee the development of and play a key role in defining the strategic vision of oncology clinical trials at Massey. He will collaborate with laboratory and clinical investigators of the cancer center’s various scientific programs as well as with its oncology clinicians to fashion a clinical trials menu that reflects both the strengths of Massey’s science and the cancer burden of its patients. He will also work closely with the associate director of translational research, Steven Grant, M.D., to create a seamless pathway for moving promising new scientific concepts into clinical trials.

“We are very pleased to welcome Dr. Geyer to Massey to direct our clinical research enterprise,” said Gordon D. Ginder, M.D., director of VCU Massey Cancer Center. “He brings substantial expertise and experience to a leadership position critical to Massey’s long-term growth and continued success as Virginia’s largest provider of cancer clinical trials.”

“Dr. Geyer’s prominence as a breast cancer specialist further strengthens our division’s excellence in patient care, research and education,” said Steven Grossman, M.D., Ph.D., chair of the Division of Hematology, Oncology and Palliative Care. “His addition will not only benefit the cancer center and university, but also the cancer community across Virginia.”

Geyer received his undergraduate and medical degrees from Texas Tech. He completed a residency in internal medicine and fellowship in medical oncology at Baylor College of Medicine Affiliated Hospitals, and he served as chief medical resident at Houston Veterans Administration Medical Center. He and his wife, Joni, have four children.

Related News

Get access to new, innovative care

Get access to new, innovative care

Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.

Search clinical trials
Find a provider

Find a provider

Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.

Find a provider